Correlation Between Dermata Therapeutics and Transcode Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Transcode Therapeutics, you can compare the effects of market volatilities on Dermata Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Transcode Therapeutics.

Diversification Opportunities for Dermata Therapeutics and Transcode Therapeutics

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dermata and Transcode is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Transcode Therapeutics

Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.14 times more return on investment than Transcode Therapeutics. However, Dermata Therapeutics is 1.14 times more volatile than Transcode Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  384.00  in Dermata Therapeutics on August 29, 2024 and sell it today you would lose (274.00) from holding Dermata Therapeutics or give up 71.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dermata Therapeutics  vs.  Transcode Therapeutics

 Performance 
       Timeline  
Dermata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Transcode Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dermata Therapeutics and Transcode Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dermata Therapeutics and Transcode Therapeutics

The main advantage of trading using opposite Dermata Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.
The idea behind Dermata Therapeutics and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data